Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4276
Protara Therapeutics
TARA
$160M
| $169K | ﹤0.01% |
55,639
-37,600
| -40% | -$130K |
2024 Q4
2 quarters
|
|
4277
Innovator US Equity Buffer ETF October
BOCT
$291M
| $168K | ﹤0.01% |
3,706
+264
| +8% | +$11.3K |
2025 Q1
1 quarter
|
|
4278
Direxion Daily NVDA Bull 2X ETF
NVDU
$565M
| $168K | ﹤0.01% |
1,700
+250
| +17% | +$16.5K |
2023 Q4
6 quarters
|
|
4279
CSP Inc
CSPI
$76.3M
| $166K | ﹤0.01% |
12,862
+12,791
| +18,015% | +$184K |
2024 Q3
3 quarters
|
|
4280
Innovator US Equity Buffer ETF August
BAUG
$272M
| $166K | ﹤0.01% |
3,606
-128
| -3% | -$5.52K |
2024 Q4
2 quarters
|
|
4281
Pro-Dex
PDEX
$205M
| $165K | ﹤0.01% |
+3,784
| New | +$185K |
2025 Q2
0 quarters
|
|
|
BIOA
4282
BioAge Labs
BIOA
$303M
| $165K | ﹤0.01% |
39,961
+27,234
| +214% | +$110K |
2024 Q3
3 quarters
|
|
4283
Future Fuel
FF
$226M
| $164K | ﹤0.01% |
42,287
+16,007
| +61% | +$64.4K |
2016 Q3
35 quarters
|
|
4284
CALL
Charter Communications
CHTR
$12.5B
| $164K | ﹤0.01% |
+400
| New | +$153K |
2025 Q2
0 quarters
|
|
4285
TriSalus Life Sciences
TLSI
$266M
| $163K | ﹤0.01% |
29,937
+29,905
| +93,453% | +$160K |
2025 Q1
1 quarter
|
|
4286
FT Vest US Equity Buffer ETF December
FDEC
$1.33B
| $163K | ﹤0.01% |
3,490
+2,334
| +202% | +$103K |
2024 Q3
3 quarters
|
|
4287
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$66.7M
| $162K | ﹤0.01% |
4,529
-850
| -16% | -$29.1K |
2024 Q3
3 quarters
|
|
4288
State Street SPDR S&P China ETF
GXC
$448M
| $161K | ﹤0.01% |
1,844
| – | – |
2020 Q4
18 quarters
|
|
4289
Crexendo
CXDO
$197M
| $161K | ﹤0.01% |
26,524
+19,792
| +294% | +$103K |
2024 Q3
3 quarters
|
|
4290
Journey Medical
DERM
$187M
| $161K | ﹤0.01% |
+22,403
| New | +$155K |
2025 Q2
0 quarters
|
|
4291
FT Vest US Equity Moderate Buffer ETF November
GNOV
$299M
| $160K | ﹤0.01% |
4,381
+940
| +27% | +$32.7K |
2025 Q1
1 quarter
|
|
4292
Consumer Portfolio Services
CPSS
$199M
| $160K | ﹤0.01% |
16,230
+6,941
| +75% | +$63.7K |
2022 Q2
12 quarters
|
|
4293
Kenon Holdings
KEN
$3.15B
| $158K | ﹤0.01% |
3,812
-3,372
| -47% | -$113K |
2023 Q2
8 quarters
|
|
|
JUNM
4294
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$67.4M
| $158K | ﹤0.01% |
4,755
-1,561
| -25% | -$49.9K |
2024 Q3
3 quarters
|
|
4295
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $158K | ﹤0.01% |
3,847
-354
| -8% | -$13.8K |
2024 Q3
3 quarters
|
|
4296
PrimeEnergy Resources
PNRG
$324M
| $158K | ﹤0.01% |
1,078
-669
| -38% | -$116K |
2023 Q2
8 quarters
|
|
|
XIFR
4297
XPLR Infrastructure LP
XIFR
$980M
| $158K | ﹤0.01% |
19,226
-1,627
| -8% | -$14.1K |
2017 Q3
31 quarters
|
|
4298
NET Power
NPWR
$123M
| $157K | ﹤0.01% |
63,525
+41,289
| +186% | +$86.7K |
2023 Q4
6 quarters
|
|
4299
Innovator US Equity Accelerated Plus ETF April
XTAP
$18.8M
| $155K | ﹤0.01% |
4,056
-100
| -2% | -$3.6K |
2024 Q3
3 quarters
|
|
4300
Kyverna Therapeutics
KYTX
$385M
| $155K | ﹤0.01% |
50,394
-30,996
| -38% | -$76.7K |
2024 Q1
5 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.